Hims Hers Health is trading at $32.26 (down 4.2%) as investors rotate out of growth names during a broad tech-led risk-off move.
- The stock is sliding alongside weakness in the Nasdaq and AI-related names, as it is being treated as a high-growth, tech-adjacent telehealth play.
- The decline occurs despite the broader healthcare sector outperforming today following strong results from UnitedHealth.
- There are no new company-specific news or regulatory developments driving the current downward price action.